Somerset Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Somerset Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,660	Closed	-$360K	–	76
2021 Q1	$360K	Buy	+1,660	New	+$312K	0.27%	57
2020 Q3	–	Sell	-1,885	Closed	-$231K	–	68
2020 Q2	$231K	Buy	+1,885	New	+$214K	0.23%	58
2020 Q1	–	Sell	-1,954	Closed	-$204K	–	67
2019 Q4	$204K	Sell	1,954 -6,735	-78%	-$755K	0.18%	69
2019 Q3	$999K	Buy	8,689 +3,436	+65%	+$522K	0.85%	31
2019 Q2	$906K	Buy	+5,253	New	+$909K	0.77%	33

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Somerset Group's GWPH Position: Q2 2021 in Review

Somerset Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,660 shares — an estimated $360K sold.

Somerset Group first reported a position in GWPH in Q2 2019 and held it in 5 quarters. The position peaked at $999K in Q3 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Somerset Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Somerset Group sold 1,660 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $360K.
Somerset Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 5 quarters.
Somerset Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $999K in Q3 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Somerset Group's 13F filing for Q2 2021, filed 10 Aug 2021.